The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their crucial role in global healthcare. This move reinforces India’s position as a key provider of affordable generic medicines. Leaders highlight the strategic importance of the bilateral trade relationship, with the exemption offering India a chance to enhance its pharmaceutical sector.
Related Posts
‘NDA has majority’: Rijiju on oppn’s no-confidence motion against Dhankhar
Union Minister Kiren Rijiju dismissed the opposition’s no-confidence motion against Rajya Sabha Chairman Jagdeep Dhankhar, citing the NDA’s majority and Dhankhar’s commitment to public welfare. […]
SC considers Owaisi’s plea seeking to maintain 1991 places of worship law
The Supreme Court will hear Asaduddin Owaisi’s plea on February 17, which calls for the enforcement of the 1991 Places of Worship Act. This act […]
Bengaluru techie suicide: Atul’s estranged wife was living as paying guest
Bengaluru police arrested a woman, her mother, and brother for allegedly abetting the suicide of the woman’s husband, an automobile executive. The trio were apprehended […]